opioid policy

Did you honestly believe that the CDC announcement six months ago – of a 4.1% decline in drug overdoses in 2018 – was a sign of progress in the so-called war on drugs? Of course, it was nothing of the sort. Just an exercise in tweaking numbers. ACSH advisor Dr. Jeff Singer tells us the real story.
Ontario may be cold, but the same cannot be said of its chief medical officer. Let's hear it for Dr. Nancy Whitmore, the head of the College of Physicians and Surgeons of Ontario. She has the ethics and the courage to make changes in policy that should have never been in place to begin with. Barbaric forced tapering will no longer be permitted, and doctors and patients will make treatment plans together. The U.S. should be looking north.
Can the FDA's tactics – to impact the current opioid problem – also predict its successor? The goal is to head off escalation before problems are crises, and the move is a departure from the status-quo, reactive nature of prior policies.